Introduction

24
Increasing interest in sustainable production of a wide range of chemical products has encouraged 25 development of microbial catalysts for the conversion of renewable feedstocks to specialty and bulk 26 chemicals as well as transportation fuels. While natural hosts and metabolic pathways have been used 27 for decades in the production of chemical products, the desire to synthesize direct replacements for 28 current petroleum products has led to appropriation of natural pathways for production of noncognate 29 chemicals 1, 2, 3 . Early examples of this new paradigm have focused on introducing or combining portions 30 of natural pathways in alternative host organisms or creating new products by altering the termination 31 of natural pathways of a host organism with promiscuous enzymes 1, 3, 4, 5, 6, 7, 8, 9, 10, 11 . Recent work has 32 been focused on improving modified natural pathways by substituting new enzymes to improve kinetics, 33 improve expression, or utilize alternate cofactors 12, 13, 14 . In some cases, pathways have been 34 repurposed to synthesize new products by capitalizing on the natural capacity of enzymes to accept 35 closely related substrates or by engineering protein specificity 15, 16, 17 . The boldest designs have utilized 36 previously undescribed pathways created by combining the natural chemistry of individual enzymes 37 from multiple hosts 18, 19, 20 . 38
Liquid transportation fuels are one class of chemical targets for which natural pathways to exact 39 replacements have not been discovered. Recent interest in microbial production of renewable fuels has 40 led to successful synthesis of a variety of next-generation biofuels with improved properties over 41 ethanol 12, 14, 15, 21, 22, 23, 24, 25, 26, 27 . Microbial synthesis of these reduced chemical species by de novo 42 designed pathways can potentially lead to more efficient production strains which are necessary for 43 next-generation targets to achieve commercial relevance. Predominantly these pathways have 44 employed reconstitution of natural pathways in new hosts (acetone-butanol-ethanol (ABE) 5, 6, 28 ) or 45 modified termination of natural pathways (fatty acid synthesis (FAS) 11, 23, 24 , amino acid synthesis 12, 29 , 46 isoprenoid synthesis 22 ). 47
While natural metabolites of lipid and terpene synthesis closely resemble biodiesel, there are few 48 natural metabolites that closely mimic gasoline. Because gasoline constitutes 40% of total U.S. 49 petroleum consumption, a bio-based gasoline alternative would be useful for alleviating petroleum 50 reliance. Two synergistic approaches are required for making a bio-based gasoline more economical: 51 utilization of less expensive feedstocks and implementation of high efficiency pathways 30, 31, 32, 33 . The 52 presented work focuses on development of a high efficiency pathway for a bio-alternative alcohol for 53 spark ignition engines. Such an alcohol would ideally fall in the C6-C7 range 25, 26, 34 . These medium-54 chain length alcohols achieve energy density equal to that of petroleum derived gasoline (32 MJ/L) (Fig. 55 S1A) 35, 36, 37, 38 . Branched alcohols have the additional desired property of improved octane rating (Fig. 56 S1B) 34 . To date, the best examples of synthesizing such compounds have come from modified 57 termination of branched amino acid synthesis or from isoprenoid synthesis 22, 29 . The amino acid based 58 pathway utilizes carbon chain extension by engineering α-ketoacid elongation (αKAE) enzymes and an α-59 ketoacid decarboxylase to produce a blend of alcohols (Fig. 1A) . The inefficient carbon chain extension 60 mechanism creates a redox imbalance for medium-chain products, which limits maximum pathway 61 efficiency 39 . The isoprenoid pathway can be used to produce C5 isopentenol, but it is limited to forming 62 carbon chain lengths in multiples of five because it uses isopentenyl diphosphate (IPP) as a C5 building 63 block, and it is limited by the inherent redox imbalance of the pathway. 64
Here, we present a pathway design which combines a portion of a native pathway (valine biosynthesis) 65 with a ten step de novo pathway to produce 4-methyl-pentanol. In order to identify specific pathway 66 variants, we utilized a conceptual modular framework based on general natural chemistries. 67
Biosynthetic routes to alkyl chains most commonly employ a system of precursor generation followed by 68 chain elongation through carbon-carbon bond forming reactions 40, 41, 42 . We structured our conceptual 69 modules to correspond to this pathway structure. We envisioned precursor generating modules 70 (Glycolysis and Modules 1 and 2) and carbon chain elongation modules (Module 3) coupled to alcohol 71 terminating modules (Module 4) . 72
This approach produced a pathway with enzymes selected from nine different metabolic contexts 73 (organsims and/or pathways) (Fig. 1B and 1C) . Four enzymes were selected to act on their presumed 74 cognate substrates and 6 were applied to presumed noncognate substrates in the engineered pathway. 75
The core Module 3 pathway architecture is based on synthetic CoA-dependent chemistry first 76 understood in the ABE pathway of Clostridium acetobutylicum. This CoA-dependent architecture has 77 several advantages compared to the αKAE and isoprenoid pathways described above. Biosynthetic CoA-78 dependent pathways typically utilize acetyl-CoA building blocks and extend carbon chains through 79 condensation reactions without release of CO 2 . The potential for generation of two reducing 80 equivalents per acetyl-CoA generated from glycolysis perfectly balances with those consumed for 81 reduction to a primary alcohol product 15, 43 . Indeed, the presented pathway achieves redox neutrality 82 and a maximum theoretical yield of 0.67 mol 4MP/mol glucose (0.38 g/g, 100% maximum pathway 83 energy efficiency). β-oxidation chemistry has been used for synthesis of several straight-chain acids and 84 alcohols 5, 6, 16, 21, 44 . Unlike these previous demonstrations of CoA-dependent pathways, here we present 85 the expansion of potential products to branched alcohols of medium chain length using independently 86 selected enzymes chosen to enhance specificity for our desired intermediates. 87
Results
88
4MP Pathway Description. The 4MP pathway design does not rely on the simple transfer of a single 89 recombinant pathway; rather, it relies on a patchwork of enzymes from multiple organisms and multiple 90 natural pathways (Fig. 1A and 1B) . Figure 1 presents the overall pathway as a composite of 4 modules. 91
Module 1, an adaptation of previously described routes to isobutanol and isobutyrate 12, 45 , converts 92 pyruvate, from glycolysis, to α-keto-isovalerate (α-KIV) via valine biosynthesis using Supplementary Fig. S2 for enzyme cofactor requirments and byproduct reactions). 107
Throughout this manuscript, strain names indicate the modules present in the strain (i.e., M1F2I34 108 includes "M" for modules, "1F" for Module 1 with feaB Ec , "2I" for Module 2 with ibuA Rp , "3" for Module 109 3, and "4" for Module 4). Strain names with "( )" contain abbreviations for operon structure indicating 110 the order of alsS Bs and ilvC Ec (i.e., M1F(IA)2I34 includes (IA) indicating an ilvC Ec -alsS Bs operon order). See 111 Table 1 and Supplementary Table S1 for descriptions of all strains used and Supplementary Table S2 Assays were devised to confirm activity on desired substrates in vitro and in vivo. First, N-terminal His-131 tagged Car Ni was purified and assayed for relative activity on 13 straight and branched acid substrates 132 from C2-C8. Car Ni showed a peak in activity for acids with a primary chain-length of 5-6 carbons (Fig.  133   2A) . The highest Car Ni activity was found for the branched species 4MV and 4-methyl-hexanoate. Given 134 the need to reduce flux of precursors to undesired byproduct alcohols, Car Ni was a logical selection 135 because of its preference for 4MV over the short-chain acids acetate, isobutyrate, and butyrate. A 136 complementary in vivo assay was designed to examine the effectiveness of the Module 4 pairing. 137
Butyrate, valerate, 3-methyl-valerate, 4MV, and hexanoate were fed to E. coli cultures expressing 138 Car Ni /Adh6p Sc and conversion was monitored by sampling the culture media. OD 600 -normalized 139 conversions followed a trend similar to observed in vitro results with maximal conversion for substrates 140 with C5 primary chain length, as desired ( Supplementary Fig. S3 ). 141
Strong specificity of Car Ni for 4MV over isobutyrate was desired because isobutyrate is produced as an 142 upstream intermediate. The Michaelis-Menten kinetic parameters of Car Ni were found using these two 143 key intermediates to confirm the desired specificity (Fig. 2B) . The k cat /K m ratio with 4MV was found to 144 be 450 times higher than with isobutyrate, indicating the significant preference of Car Ni for 4MV over 145 other acid substrates generated by the pathway. With a K m of 78 ± 9 mM with isobutyrate, Car Ni is 146 expected to convert isobutyrate poorly under physiologically relevant concentrations, which limits 147 shunting of the precursor to isobutyraldehyde. 148
Identification of Dehydratases and Reductases for Synthesis of 4MV (Module 3). Enzymes of the 149
Clostridium acetobutylicum butanol pathway and enzymes from polyhydroxyalkanoate pathways have 150 previously been used to synthesize straight chain butanol and pentanol 14, 15, 21 . Previous work from our 151 group found the bktB Cn /phaB Cn combination is capable of synthesizing 3-hydroxy-4-methylvaleryl-CoA 152 from isobutyryl-CoA and acetyl-CoA
51
. To the best of our knowledge, 3-hydroxy-acyl-CoA dehydratases 153 and trans-enoyl reductases with activity on the subsequent branched intermediates have not been 154 identified. From enzymes documented to have activity on straight medium-chain CoA substrates, 4 phaJ 155 and 6 ter homologs were selected for further screening 49, 50 (Supplementary Table S1 ). An assay was 156 developed to screen for enzymes with the desired activity by isolating Modules 2 and 3 of our pathway 157 in vivo with different combinations of dehydratases and reductases. Isobutyrate (10 mM) and glucose 158 (1%) were supplied in LB medium, and active gene combinations were identified by detecting 4MV 159 secretion. The propionyl-CoA transferase from Megasphera elsdenii, pct Me , was used to activate 160 isobutyrate 63 . Of the 24 combinations tested, phaJ4 homologs from Pseudomonas syringae, 161
Pseudomonas aeruginosa, and C. necator in combination with ter homologs from Vibrio 162 parahaemolyticus and T. denticola produced 4MV (Supplementary Fig. S4A ). The high producer, C. 163 necator phaJ4b Cn /T. denticola ter Td (Strain M3Sc-TdCn), yielded 297 ± 45 mg/L 4MV and was selected for 164
Module 3 moving forward. The previously used dehydratase hbd Ca and reductase crt Ca from the 165
Clostridium acetobutylicum butanol pathway were also tested in place of phaB Cn and phaJ4b Cn (Strain 166 M3Sc-Ca) ( Supplementary Fig. S4B ). While some butyrate was produced by Strain M3Sc-Ca, 4MV was 167 not detected. 168
With Module 4 in vivo activity previously confirmed, 4MP production from glucose and isobutyrate was 169 tested with a strain expressing Module 2, 3, and 4 genes (Strain M2P34). As predicted by observed 170 activities for Car Ni and Adh6p Sc , Strain M2P34 preferentially produced 4MP (272 ± 7 mg/L) over 171 isobutanol (111 ± 7 mg/L) and butanol (142 ± 9 mg/L) even while feeding 10 mM (870 mg/L) isobutyrate 172 ( (Fig. 3A, Supplementary Fig. S6C ). (Fig.  218   3B ). Isobutyrate titers (424 ± 9 mg/L, 0.084 ± 0.004 mol/mol glucose) were increased and isobutanol 219 titers (797 ± 7 mg/L, 0.187 ± 0.006 mol/mol glucose) were reduced (Fig. 3C) . 220
In order to examine if alcohol toxicity could be limiting product titers, toxicities of the dominant 221 byproduct isobutanol and desired product 4MP were assayed through exogenous addition of alcohols to 222 the growth medium at concentrations from 1-10 mM. Isobutanol and 4MP concentrations up to 5 mM 223 did not inhibit the exponential growth rate (Supplementary Fig. S7 ). A combination of 10 mM (741 224 mg/L) isobutanol and 2 mM (204 mg/L) 4MP (comparable to titers observed for Strain M1Fj(IA)2I34) 225 only reduced the exponential growth rate by 10%, the same reduction observed with 10 mM isobutanol 226 alone. While endogenously produced alcohols may be involved in alternative toxicity mechanisms, this 227 result suggests that current titers are likely not limited by product toxicity. 228
Achieving Pathway Selectivity through Enzyme Selection (Revisiting Module 4). With knowledge of the 229 specificity of Car Ni for 4MV over isobutyrate, the continued high isobutanol titers suggested Adh6p Sc was 230 converting the isobutyraldehyde intermediate to isobutanol (Fig 4A) . Removing ADH6 Sc from Strain 231 M1F(IA)2I34 produced Strain M1F(IA)2I34a which generated an isobutanol titer of 27 ± 3 mg/L with 232 nearly undetectable butanol and 4MP titers (Fig. 4B) Selective synthesis of 4MP was achieved over other alcohol byproducts (Fig 4C) . Isobutanol titers were 237 reduced to 21 ± 3 mg/L similar to those observed with the no alcohol dehydrogenase control. 4MP was 238 produced at 90 ± 7 mg/L (0.016 ± 0.001 mol/mol glucose) making up 81% of all alcohol products. The 239 dominate byproducts were the 4MP precursors acetate (592 ± 34 mg/L, 0.177 ± 0.010 mol/mol glucose) 240 and isobutyrate (1128 ± 34 mg/L, 0.229 ± 0.002 mol/mol glucose), suggesting that byproduct shunts 241 were reduced and further improvement could be made by relieving a downstream rate limitation in 242 Module 2, 3, or 4 ( Supplementary Fig. S8 ). While 4MP titers were lower with Lsadh Ls , SDS-PAGE analysis 243 of Lsadh Ls confirmed strong overexpression in E. coli ( Supplementary Fig. S8C ). The reduction in titer is 244 likely due to the change from an NADPH-dependent dehydrogenase (Adh6p Sc ) to an NADH-dependent 245 dehydrogenase (Lsadh Ls ) under the aerobic conditions used. (Fig. 2 and 4 (Fig. 3) . Combining more selective 300 alcohol and aldehyde dehydrogenases led to a highly selective overall pathway with the major 301 byproduct being overflow of the upstream intermediate isobutyrate (Supplementary Fig. S6 ). Together 302 the results from alcohol and aldehyde dehydrogenase selection highlight the importance of considering 303 both high activity and required selectivity when utilizing retro-biosynthetic screening. Proposing 304 potential upstream pathways is required to identify intermediates which could have cross-reactivity 305 with downstream enzymes. 306
Further engineering of the CoA-dependent 4MP pathway is warranted given the potential high energy 307 yield. Dugar and Stephanopoulos have outlined the importance of balancing reducing equivalents 308 generated and consumed in a recombinant pathway if high yields are desired The reducing equivalents of the pathway are balanced, but some are contained in different cofactors. 314
The maximum pathway energy efficiency ( P γ ) can be calculated using the degrees of reductance and 315 pathway stoichiometry for a glucose substrate and 4MP product. Maximum pathway energy efficiency 316 for the αKAE pathway and the presented CoA-dependent pathway are 75% and 100%, respectively. 317
Accounting for cofactor requirements, the adjusted pathway energy efficiencies ( potential efficiency and selectivity make our CoA pathway a preferred candidate for future engineering. 331
Currently, the major byproducts of the CoA-dependent route are the acids acetate, isobutyrate, and 332 butyrate (Fig. S8) . We expect that a combination of tuning thioesterase/transferase activities of the 333 host to selectively cleave the longer 4-methyl-valeryl-CoA intermediate and relieving Module 3 rate 334 limitations will further enhance titers. Ultimately, screening or engineering for NADH-dependent 335 enzymes should produce a high yielding fermentative pathway. Our existing pathway can also be 336 adapted to produce other branched medium-chain products by testing new downstream modules. 337
Finally, we believe the pathway design approach described here can be useful for creation of new 338 metabolic pathways which rely on long de novo routes. Using retro-biosynthetic screening within a 339 proposed pathway framework allows exploration of diversity using a small number of assays while 340 constraining enzyme space to a chemical route which is maximally efficient for a given product. 341
342
Methods
343
Bacterial Strains and Plasmids: E. coli MG1655(DE3) ΔendA ΔrecA described previously was the host 344 strain for production experiments, alcohol toxicity experiments and for protein expression analysis using 345 The compatible vector set pETDuet-1, pCDFDuet-1, pACYCDuet-1, and pCOLADuet-1 was used to express 365 single genes or synthetic operons under control of a T7lac promoter and individual ribosome binding 366 sites. Plasmids were constructed using standard molecular biology techniques with restriction enzymes 367 and T4 DNA ligase purchased from New England Biolabs. Ligation products in pETDuet-1, pACYCDuet-1, 368 and pCOLADuet-1 were used to transform E. coli DH10B and pCDFDuet-1 products were used to 369 transform E. coli ElectroTen-Blue. Propagated constructs were purified using a QIAprep Miniprep Kit 370 (Qiagen, Valencia, CA) and agarose gel fragments were purified using a Zymoclean Gel DNA Recovery Kit 371 (Zymo Research, Irvine, CA). Completed constructs were used to co-transform E. coli MG1655(DE3) 372
ΔendA ΔrecA. (See Supplemenatry Table S3 for plasmid details). 373
Splice by Overlap Extension: Initial PCR products with homologous ends were added to a PCR mixture 374 without additional primers and cycled through a standard PCR cycle 4 times with annealing 375 temperatures set at 6°C above, 3°C above, and at the designed melting temperature for the homology. 376
The upstream primer for the upstream gene and the downstream primer for the downstream gene in 377 the designed operon were then added to amplify the full length product. A standard PCR method using 378 the annealing temperature for the primer pair was used for final amplification. 379
Culture Conditions: For all production experiments triplicate seed cultures were grown from isolated 380 colonies at 30°C overnight in 3 ml LB medium in a 14 ml culture tube on a rotary shaker at 250 rpm. All 381 production cultures were inoculated with 1% inoculum from overnight seed culture and grown at 30°C 382 on a rotary shaker at 250 rpm. Cultures were induced with 0.5 mM IPTG when OD 600 values reached 0.6-383 1.0 corresponding to mid-exponential phase. For constructs designed for 4MV production 50 ml 384 cultures in 250 ml shake flasks were used, and for constructs designed to produce 4MP 3 ml cultures in 1 385 inch diameter 50 ml screw-cap culture tubes (Pyrex VISTA) were used. Unless otherwise stated, 1 ml 386 culture samples were taken 48 hours post induction, centrifuged to pellet cells, and the supernatant was 387 removed for analysis. 388
For production of 4-methyl-valerate and 4-methyl-pentanol from glucose and isobutyrate, LB medium 389 supplemented with 1% glucose and 10 mM isobutyrate was used. For production of 4-methyl-valerate 390 and 4-methyl-pentanol from glucose, LB medium supplemented with 1.2% glucose was used. Samples 391 were taken 48 hours post induction except for initial experiments with Strains M1F2P34 and M1P2P34 392 when samples were taken 72 hours post induction. 393
For assessing toxicity of isobutanol and 4MP, an MG1655(DE3) ΔendA ΔrecA seed culture was grown 394 overnight in LB medium. Duplicate 3 ml cultures in LB + 1.2% glucose + alcohol were inoculated to an 395 initial OD 600 of 0.1. Cultures were contained in the same 50 ml screw-cap tubes used in production 396 experiments. Cultures contained 1 mM isobutanol, 5 mM isobutanol, 10 mM isobutanol, 1 mM 4MP, 5 397 mM 4MP, 10 mM 4MP, or no alcohol. Growth was monitored by optical density and the growth rate 398 was calculated from a linear regression of the natural log of the OD 600 values for the 1.5, 2, and 2.5 hour 399 post-inoculation time points. 400
Relative Activity Assay for Purified his-Car: An overnight culture of BL21 Star (DE3) (Invitrogen) 401 harboring pET/His-Car-RBS2-Sfp was used as 10% (v/v) inoculum in 2 L of LB Broth. The culture was 402 incubated at 30°C and 250 rpm, and expression was induced using a final concentration of 1 mM IPTG at 403 OD 0.6. Cells were harvested after 20 hours using centrifugation and resuspended in a buffer containing 404 50 mM Tris-HCl pH 8.0, 300 mM NaCl, and 10% glycerol. Cells were subsequently lysed using sonication. 405
The supernatant was collected and applied to a column containing Ni-NTA resin (Qiagen). Affinity 406 chromatography was performed using step-wise increasing concentrations of imidazole. Fractions 407 containing purified His6-Car were dialyzed overnight at 4°C into 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 408 mM DTT, and 10% glycerol. Dialyzed enzyme was then flash frozen using liquid nitrogen and stored at -409
80°C. 410
The activity of His-Car on various substrates was determined by measuring changes in absorbance at 340 411 nm for up to 5 minutes in 96-well microplates (Tecan Infinite F200 Pro). Reactions were prepared as 412 follows: 100 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 0.6 mM NADPH, 1 mM ATP, 224 nM His-Car, and 50 mM 413 pH neutralized acid substrate. All substrates were assayed in triplicate. For K M and V max determinations, 414 substrates were assayed at 5 different concentrations. 415 SDS-PAGE Analysis: E. coli MG1655(DE3) ΔendA ΔrecA was transformed with empty pETDuet-1, pET-416
pACYC-(car Ni -sfp Bs )-lsadh Ls . Single colonies from plates of each transformation were grown overnight in 418 3 ml of LB with appropriate antibiotic. Shake flask cultures (250 ml flasks) containing 50 ml LB + 0.6% 419 glucose were inoculated at 1% inoculum from overnight LB cultures and incubated with agitation at 30°C 420 and 250 rpm. Shake flasks were induced with 0.5 mM IPTG OD 600 values between 0.5 and 0.6. 421
Five and a half hours after induction 7 ml of each culture were sampled and pelleted by centrifugation. 422
Cell pellets were resuspended in 1 ml of 10 mM Tris-HCl at pH 8.0 and added to 1.7 ml microcentrifuge 423 tubes containing 500 ul of 0.1 mm diameter glass beads (Scientific Industries, Inc. Disruptor Beads, SI-424 BG01). Samples were then vortexed for 10 minutes. 425
After lysis, samples were pelleted by centrifugation (6,000g, 4°C, 10 min) and the supernatant was 426 removed as soluble lysate. Total protein was quantified by a previously described Bradford assay 427 method using Bio-Rad Protein Assay Dye Reagent (Cat #500-0006) 71 . A Bio-Rad 10% Mini-PROTEAN TGX 428 gel (Cat #456-1034) was run using the Mini-PROTEAN Tetra Cell electrophoresis set up. Bio-Rad 429 Precision Plus Protein All Blue Standard (Cat #161-0373) and 10 μg of total protein for each sample was 430 loaded on the gel. After running at 200 volts for 33 minutes, the gel was washed with deionized water 431 before staining with Bio-Rad Bio-Safe Coomassie Stain (Cat #161-0786). 432
Metabolite Analysis: Culture samples were pelleted by centrifugation and supernatant was removed 433 for HPLC analysis with an Agilent 1200 series instrument with a refractive index detector. Analytes were 434 separated using the Aminex HPX-87H anion exchange column (Bio-Rad Laboratories, Hercules, CA) with 435 a 5mM sulfuric acid mobile phase at 35°C and a flowrate of 0.6 ml/min. Figure 1 : 4-methyl-pentanol (4MP) pathway schematic and alternative biofuel pathways. (A) The α-ketoacid elongation (αKAE) pathway was previously used to synthesize 4MP among other products. The αKAE route utilizes relatively inefficient single-carbon extension and non-specific decarboxylation and reduction of upstream precursors resulting in a redox imbalance and a mix of products, three of which are shown. (B) Thepresented CoAdependent pathway to 4MP is assembled with genes from 9 organisms taken from 10 different pathway contexts. Pathway genes are shown with known native pathways or putative metabolic roles. Selectivity for 4MP was achieved while requiring enzymes for Modules 3 and 4 to act on noncognate substrates. (C) The 4MP pathway can be organized into 4 modules which were used to identify better performing enzymes for individual steps and validate portions of the overall pathway independently in vivo: Module 1, modified valine biosynthesis to isobutyrate; Module 2, isobutyrate activation to isobutyryl-CoA; Module 3, CoA-dependent condensation and reduction of isobutyryl-CoA and acetyl-CoA to 4-methyl-valerate (4MV); Module 4, reduction of 4MV to 4MP. Genes in italics were overexpressed from plasmid sets. Modules were constructed working backwards from the 4MP product. A potential byproduct shunt to butyrate and butanol was monitored during pathway construction. In vitro analysis of his-purified Car Ni reveals a dependence on acid primary-chain length with maximum activity at a chain length of five and six carbons. Branching at the C4 position is preferred significantly over straight acid species. The potential substrates for byproduct formation, butyrate and isobutyrate, are seen to have 56% and 25% of the observed activity on 4-methyl-valerate (4MV) respectively. (B) Michaelis-Menten kinetics for isobutyrate and 4MV reveal that Car Ni has a strong preference for the latter intermediate. (C) Car Ni substrate preference influences product selectivity in vivo generating 1.9 times as much 4-methyl-pentanol (4MP) (272 mg/L, 2.7 mM) as butanol (142 mg/L, 1.9 mM) in Strain M2P34 (expressing Module 2(pct), 3, and 4 genes) supplied with both glucose and isobutyrate. Even though 10 mM isobutyrate is supplied to the cultures of Strain M2P34 only 111 mg/L (1.5 mM) isobutanol is observed. All data are presented as the mean ± s.d. (n=3) with in vivo data generated using biological triplicates. 
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